Preparation and characterization of flurbiprofen beads by melt solidification technique

AAPS PharmSciTech

Volumn 4, Issue 4, 2003, Pages

  Paradkar, Anant ^a   Maheshwari, Manish ^a   Tyagi, Amit Kumar ^a   Chauhan, Bhaskar ^a   Kadam, S S ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Cetyl alcohol; Factorial design; Flurbiprofen; Melt solidification technique; Response surface methodology; Zero order kinetics

Indexed keywords

ALCOHOL; EXCIPIENT; FLURBIPROFEN; FATTY ALCOHOL; HEXADECANOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRUSHING STRENGTH; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG SYNTHESIS; EMULSION; GLASS TRANSITION TEMPERATURE; INFRARED SPECTROSCOPY; LOW TEMPERATURE; MELTING POINT; MULTIPLE REGRESSION; PARTICLE SIZE; RESPONSE SURFACE METHOD; SOLID; SUSTAINED DRUG RELEASE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; PHARMACEUTICS; TRANSITION TEMPERATURE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EMULSIONS; FATTY ALCOHOLS; FLURBIPROFEN; TECHNOLOGY, PHARMACEUTICAL; TRANSITION TEMPERATURE;

EID: 23144462229     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt040465     Document Type: Article

References (12)

1. Bodmeier R, Wang J, Bhagwatwar, H. Process and formulation variables in the preparation of wax microparticles by melt dispersion technique for water insoluble drugs. J Microcapsul. 1992;9:89-98.
2. Schaefer T, Holm P, Kristensen HG. Melt granulation in a laboratory scale high shear mixer. Drug Dev Ind Pharm. 1990;16:1249-1277.
3. Nadia P, Beatrice A, Cristina C, Lorenzo R. Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation. Eur J Pharm Sci. 2002;15:71-78.
4. Gokonda SR, Hileman GA, Upadrastha SM. Development of matrix controlled release beads by extrusion-spheronozation techniques technology using a statistical screening design. Drug Dev Ind Pharm. 1994;20:279-292.
5. Kim JW, Ulrich J. Prediction of degree of deformation and crystallization time of molten droplets in pastillation process. Int J Pharm. 2003;257:205-215.
6. Barthelemy P, Laforet JP, Farah N, Joachim J. Compritol 888 ATO: an innovative hot melt coating agent for prolonged drug formulations. Eur J Pharm Biopharm. 1999;47:87-90.
7. Adeyeye CM, Price JC. Development and evaluation of sustained release ibuprofen-wax microspheres I: effect of formulation variables on physical characteristics. Pharm Res. 1991;8:1377-1383.
8. Adeyeye CM, Price JC. Development and evaluation of sustained release ibuprofen-wax microspheres II: in vitro dissolution studies. Pharm Res. 1994;11:575-579.
9. Paradkar AR, Maheshwari M, Ketkar AR, Chauhan B. Preparation and evaluation of ibuprofen beads by melt solidification technique. Int J Pharm. 2003;255:33-42.
10. Maheshwari M, Ketkar AR, Chauhan B, Patil VB, Paradkar AR. Preparation and characterization of ibuprofen-cetyl alcohol beads by melt solidification technique: effect of variables. Int J Pharm. 2003:261:57-67.
11. Gilman AG, Rall TW, Taylor P. Goodman and Gillman's the Pharmacological Basis of Therapeutics. New York, NY: Pergamon Press; 1990.
12. Jarosz PJ, Parrott EJ. Comparison of granule strength and tablet strength. J Pharm Sci. 1983;72:530-535.